SureSwab Rapid: A Groundbreaking Innovation in Oral Fluid Drug Screening

This cutting-edge design is set to refine drug screening processes, offering a less invasive and more efficient solution for workplace, rehabilitation, and clinical testing.

SureSwab Rapid is designed to enhance the donor experience by minimising invasiveness and optimising collection time. This user-friendly product ensures a streamlined testing process, making it an ideal solution for various testing environments. This innovation aligns with SureScreen Diagnostics’ commitment to providing state-of-the-art diagnostic tools that meet the evolving needs of industry professionals.

SureSwab Rapid prioritises the comfort and experience of the donor, offering a less invasive method for drug screening in oral fluid. This feature contributes to a more positive testing experience for individuals undergoing the screening process.

With a focus on efficiency, SureSwab Rapid enables rapid sample collection, reducing the overall testing time. This not only enhances operational efficiency but may also support cost savings for organisations implementing a drug screening program.

Whether in the workplace, rehabilitation facilities, or clinical settings, SureSwab Rapid can provide a simple and effective solution for drug screening. Its versatility makes it an invaluable tool for a wide range of industries and testing scenarios.

SureSwab Rapid delivers rapid negative results, allowing organisations to swiftly implement and manage efficient testing programs for employees. This not only saves time but also contributes to the overall effectiveness of drug screening initiatives.

SureSwab Rapid is poised to make a significant impact on the landscape of drug screening, providing a technologically advanced and user-friendly solution for professionals in need of accurate and timely results.

“At SureScreen Diagnostics, we are dedicated to developing innovative solutions that address the evolving challenges in drug screening. SureSwab Rapid is a testament to our commitment to improving the testing experience for both individuals and organisations” said Andrew Wilcher, Chief Executive Officer at SureScreen Diagnostics.

Find out more about how to manage drug and alcohol misuse in the workplace at the UK Health and Safety Executive or reach out to one of our expert team via [email protected]